Analysts at H.C. Wainwright initiated coverage on DARA Biosciences Inc DARA with a Buy rating.
The target price for DARA Biosciences is set to $2.
DARA Biosciences shares have dropped 59.04 percent over the past 52 weeks, while the S&P 500 index has surged 13.39 percent in the same period.
DARA Biosciences' shares rose 3.90 percent to $0.800 in pre-market trading.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in